Page last updated: 2024-09-03

ly 255283 and Ovarian Neoplasms

ly 255283 has been researched along with Ovarian Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kim, JH; Park, J; Park, SY	1

Other Studies

1 other study(ies) available for ly 255283 and Ovarian Neoplasms

Article	Year
Leukotriene B4 receptor-2 contributes to chemoresistance of SK-OV-3 ovarian cancer cells through activation of signal transducer and activator of transcription-3-linked cascade. Biochimica et biophysica acta, 2016, Volume: 1863, Issue:2 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Female; Flow Cytometry; Humans; Immunoblotting; Interleukin-6; Leukotriene Antagonists; Mice, Nude; Ovarian Neoplasms; Receptors, Leukotriene B4; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; STAT3 Transcription Factor; Tetrazoles; Tumor Burden; Xenograft Model Antitumor Assays	2016

Article

Year

Leukotriene B4 receptor-2 contributes to chemoresistance of SK-OV-3 ovarian cancer cells through activation of signal transducer and activator of transcription-3-linked cascade.

Biochimica et biophysica acta, 2016, Volume: 1863, Issue:2

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Female; Flow Cytometry; Humans; Immunoblotting; Interleukin-6; Leukotriene Antagonists; Mice, Nude; Ovarian Neoplasms; Receptors, Leukotriene B4; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; STAT3 Transcription Factor; Tetrazoles; Tumor Burden; Xenograft Model Antitumor Assays

2016